VP, US Medical Affairs — Rare Disease Leader

Ipsen Biopharmaceuticals Inc.; Cambridge (MA); On-site; USD 350,000 - 650,000; Full time

Job summary

Ipsen Biopharmaceuticals Inc. seeks a Vice President, Head of US Medical Affairs, Rare Disease, to lead the U.S. medical vision and execution across a growing rare disease portfolio.

This senior leader partners with Global Medical Affairs, R&D, Regulatory, Commercial and Market Access to shape strategy and drive post-launch evidence generation. The role encompasses marketed products, lifecycle planning, evidence development, and integration planning for acquisitions/partnerships, with emphasis

Qualifications

• Leader within medical affairs with Rare Disease expertise.
• Experience in lifecycle management and evidence generation.
• Strategic thinker able to align U.S. medical strategy with Global Medical Affairs.

Responsibilities

• Set and own the U.S. Rare Disease medical strategy, annual medical plan and engagement roadmap across rare liver, rare bone and emerging kidney/transplant priorities.
• Drive post-launch medical excellence for IQIRVO in PBC with evidence pull-through and competitive readiness.
• Lead launch readiness and lifecycle medical planning for Bylvay / Kayfanda across PFIC, ALGS and biliary atresia.
• Plan for U.S. medical strategy for new rare disease assets including kidney/BK PyV nephropathy and related programs.
• Maintain medical oversight for the FOP portfolio including Sohonos and fidrisertib close-out and inquiries.
• Represent the U.S. medical voice in Global Asset Teams and cross-functional governance bodies.
• Provide end-to-end leadership over evidence generation including US Phase IIIb/IV studies and RWE priorities.

Job description

Ipsen Biopharmaceuticals Inc. seeks a Vice President, Head of US Medical Affairs, Rare Disease, to lead the U.S. medical vision and execution across a growing rare disease portfolio.

This senior leader partners with Global Medical Affairs, R&D, Regulatory, Commercial and Market Access to shape strategy and drive post-launch evidence generation. The role encompasses marketed products, lifecycle planning, evidence development, and integration planning for acquisitions/partnerships, with emphasis